A Raafat1, A Zoltan-Jones, L Strizzi
1Oncogenetics Section, Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Notch4 Int3 overexpression drives mammary tumors in mice. Treatment with Gleevec, a tyrosine kinase inhibitor, reduced tumor growth by targeting c-Kit and PDGFR-alpha, suggesting their oncogenic role in Notch4-induced tumorigenesis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: